Trial
NCT03907124
Clinical Utility of Pharmacogenomics of Psychotropic Medications
Phase IVWITHDRAWNOPERATIONALConfidence: HIGH
Sponsor
Oregon Health and Science University
Collaborators
—
Condition
Psychiatric Disorders
Intervention
Genetically-guided treatment with FDA-approved psychotropic drugs
Why stopped
PI left institution prior to recruitment.
Provenance
Dataset: 2026-07-02 • Source: ClinicalTrials.gov API v2 • Last update: 2023-09-21